Ann: First patient dosed in Phase 1 bile tract cancer trial, page-52

Hi friend Nick

Thanks! I Truly appreciate your kind words.

We have had a long break between significant news events, and at times like that the trolls come out to play and it all gets a bit boring. Some of them are just “ monkeying around” and I don’t feel the need to engage.

Also, I’ve been busy with my own business and with family events, so I haven’t been reading all the commentary here.

For me, IMU has always been a speculative investment - and one that requires patience, but I remain very positive about their long term prospects for clinical and commercial success.

I’m fortunate that I can afford to wait for that, and most of the time I enjoy the journey. The destination is very important to me, but so is every single day. Having great fellow travellers like yourself - and many others here - makes it a lot more fun.

Best wishes

Dave




b